Pathologies of liver organ diseases demonstrate charged ASK1 signaling and blocking ASK1 in non-alcoholic steatohepatitis (NASH), a mouse model greatly reduced liver steatosis and fibrosis [68,69]. Here, MAP3K5 is linked to metabolic dysfunction-associated steatohepatitis.